https://www.taxtmi.com/news?id=68636 WuXi Biologics will provide integrated, end to end development and manufacturing services-including cell line, process and bioassay development, formulation development, and GMP manufacturing-to accelerate CMC execution, clinical translation, and scalable global development of HanchorBio's FBDBTM derived multi functional fusion protein portfolio. en-us Tue, 27 Jan 2026 10:31:05 +0530 Tue, 27 Jan 2026 10:31:05 +0530 TaxTMI RSS Generator https://www.taxtmi.com/news?id=68636 WuXi Biologics will provide integrated, end to end development and manufacturing services-including cell line, process and bioassay development, formulation development, and GMP manufacturing-to accelerate CMC execution, clinical translation, and scalable global development of HanchorBio's FBDBTM derived multi functional fusion protein portfolio. News - Tue, 27 Jan 2026 10:31:05 +0530 https://www.taxtmi.com/news?id=68636